Cleared Traditional

K193009 - Promisemed Heel Blood Lancet (FDA 510(k) Clearance)

Dec 2019
Decision
36d
Days
Class 2
Risk

K193009 is an FDA 510(k) clearance for the Promisemed Heel Blood Lancet. This device is classified as a Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (Class II - Special Controls, product code FMK).

Submitted by Promisemed Hangzhou Meditech Co., Ltd. (Hangzhou City, CN). The FDA issued a Cleared decision on December 3, 2019, 36 days after receiving the submission on October 28, 2019.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Non-reusable Base (including An Integral Sharps Injury Prevention Feature) That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. The Integral Sharps Injury Prevention Feature Allows The Device To Be Used Once And Then Renders It Inoperable And Incapable Of Further Use..

Submission Details

510(k) Number K193009 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 2019
Decision Date December 03, 2019
Days to Decision 36 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FMK — Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Non-reusable Base (including An Integral Sharps Injury Prevention Feature) That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. The Integral Sharps Injury Prevention Feature Allows The Device To Be Used Once And Then Renders It Inoperable And Incapable Of Further Use.